XML 21 R5.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]      
Revenue $ 982,021 $ 739,016 $ 563,948
Costs and operating expenses:      
Cost of revenue 349,007 289,799 227,052
Research and development expense 364,191 347,753 367,194
Sales and marketing expense 494,661 364,935 295,227
General and administrative expense 211,410 180,123 155,800
Other operating expense 0 0 83,400
Total costs and operating expenses 1,419,269 1,182,610 1,128,673
Loss from operations (437,248) (443,594) (564,725)
Interest income 34,095 53,691 35,365
Interest expense (3,897) (2,581) (2,578)
Other income (expense), net (10,490) (42,605) 53,174
Loss before (benefit from) provision for income taxes (417,540) (435,089) (478,764)
(Benefit from) provision for income taxes (1,263) 1,284 685
Net loss $ (416,277) $ (436,373) $ (479,449)
Net loss per share, basic (in usd per share) $ (3.32) $ (3.56) $ (4.28)
Net loss per share, diluted (in usd per share) $ (3.32) $ (3.56) $ (4.28)
Weighted-average shares used in computing net loss per share, basic (in shares) 125,374 122,745 111,988
Weighted-average shares used in computing net loss per share, diluted (in shares) 125,374 122,745 111,988